Ideas
Mirovα, Creating Sustainable Value - September 2024
Published on 09/23/2024
Monthly market review and outlook
Mirovα, Creating Sustainable Value - September 2024
Published on 09/20/2024
Monthly market review and outlook
Trending Forward: The growing market for GLP 1 DRUGS
Published on 07/17/2024
Investing Insights from the Sustainable Equities Team
Mirovα, Creating Sustainable Value - July 2024
Published on 07/17/2024
Bi-annual market review & outlook
Mirovα, Creating Sustainable Value - July 2024
Published on 07/17/2024
Bi-annual market review & outlook
Trending Forward: Investing Insights from the Sustainable Equity Team
Published on 07/15/2024
The growing market for GLP 1 DRUGSAs obesity rates swell worldwide, popular GLP-1 (Glucagon-like peptide-1) drugs such as Ozempic and Wegovy have generated investor interest. Demand for these drugs has outstripped supply and companies such as Novo Nordisk and Eli Lilly have a strong hold on the market share. Investors should also consider the broader market opportunities and cross-sector implications of GLP-1 drugs.
Mirovα, Creating Sustainable Value - June 2024
Published on 06/21/2024
Monthly market review and outlook
